dihexa peptide vs semax | Neuroprotective SEMAX/SELANK/DSIP Blend - Beverly Hills

L., Dahl, K., Schffer, L., Sensfuss, U., Poulsen, C., Schlein, M., Hansen, A

Acute soft tissue injuries show the highest response rates, with approximately 60 to 70 percent of users reporting clear benefit and 30 to 40 percent describing dramatic improvement

The takeaway from that table is the whole point of an honest comparison: the two rows with real strength each describe only one drug, the direct cagrilintide-vs-retatrutide row is empty, and the only cross-drug row is explicitly weak

There may be differing opinions or unique experiences

Those are useful, but there are serious limitations regarding how benefits to animals can be translated to benefits to people